ARCHIVES

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

Researchers Find Two Types Of MCL Drug Resistance

August 29, 2014

Centers Core Support To Be Trimmed By Dropping Funds for Scientists Salaries, Shared Resources

September 23, 1977

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

December 6, 2002

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

In Brief: NCI awards center Grant to Cancer Institute of New Jersey; Researcher Win Honors

April 4, 1997

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009